![]() |
|
|
My Amedeo
FAQ
Privacy
About
|
Learning 500 Chinese characters in 30 days is possible. |
| Nuclear Medicine |
|
Free Subscription
1 Ann Nucl Med |
Retrieve available abstracts of this week’s articles:
HTML format |
| Single Articles |
AMEDEO Nuclear Medicine is free of charge.
The prognostic value of multiparameters derived from D-SPECT in patients with
ANOCA.
Ann Nucl Med. 2026 Feb 19. doi: 10.1007/s12149-026-02173.
PubMed
Artificial Intelligence-Enabled Echocardiography as a Surrogate for Multimodality
Aortic Stenosis Imaging: Post Hoc Analysis of a Clinical Trial.
Circ Cardiovasc Imaging. 2025 Dec 31:e018353.
PubMed
Abstract available
Higher Life-Course Blood Pressure Associates With Reduced Myocardial Perfusion in
Older Age: Insights From MyoFit46.
Circ Cardiovasc Imaging. 2025 Nov 8:e019105. doi: 10.1161/CIRCIMAGING.125.019105
PubMed
Abstract available
Early Detection of Neuroblastoma Recurrence on 18F mFBG PET.
Clin Nucl Med. 2026 Feb 9. doi: 10.1097/RLU.0000000000006348.
PubMed
Abstract available
Appearance of Coronary Sinus Epithelioid Hemangioendothelioma on
Contrast-enhanced 18F-FDG PET/MR.
Clin Nucl Med. 2026 Feb 6. doi: 10.1097/RLU.0000000000006320.
PubMed
Abstract available
18F-FDG PET/CT in Disseminated Cryptococcosis Mimicking Malignancy With Rib
Osteolysis and Chest Wall Invasion.
Clin Nucl Med. 2026 Feb 4. doi: 10.1097/RLU.0000000000006185.
PubMed
Abstract available
(90)Y-FAPI-46 Radiopharmaceutical Therapy in Sarcoma and Other Solid Tumors: An
Updated Cohort Analysis.
J Nucl Med. 2026 Feb 19:jnumed.125.271135. doi: 10.2967/jnumed.125.271135.
PubMed
Abstract available
Advancing Theranostics in Alzheimer Disease: FDA Approval of Amyloid-beta PET Drugs
for Selection of Patients for Amyloid-beta-Directed Therapies and Other Labeling
Updates.
J Nucl Med. 2026 Feb 19:jnumed.125.271312. doi: 10.2967/jnumed.125.271312.
PubMed
Prediction of programmed death-ligand 1 expression levels in non-small cell lung
cancer patients based on 18F-fluorodeoxyglucose PET/computed tomography radiomics
features.
Nucl Med Commun. 2026 Feb 16. doi: 10.1097/MNM.0000000000002125.
PubMed
Abstract available
Somatostatin receptor PET in meningioma: diagnosis, therapy, and surveillance.
Nucl Med Commun. 2026 Feb 16. doi: 10.1097/MNM.0000000000002122.
PubMed
Abstract available
Nuclear medicine in predicting hepatocellular carcinoma response.
Nucl Med Commun. 2026 Feb 17. doi: 10.1097/MNM.0000000000002126.
PubMed
Abstract available
Predicting persistent/recurrent cervical lymph node metastasis in papillary
thyroid carcinoma with PET/CT-based multimodal radiomics: an image-pathology
matching study.
Nucl Med Commun. 2026 Feb 19. doi: 10.1097/MNM.0000000000002124.
PubMed
Abstract available
Determinants of intracranial microcalcification assessed by 18F-sodium fluoride
PET.
Nucl Med Commun. 2026 Feb 19. doi: 10.1097/MNM.0000000000002121.
PubMed
Abstract available
Role of [18F]fluorodeoxyglucose positron emission tomography-computed tomography
metabolic radiomics in predicting response to chemotherapy in patients with
non-small cell lung cancer.
Nucl Med Commun. 2026 Feb 20. doi: 10.1097/MNM.0000000000002127.
PubMed
Abstract available
Early diagnosis of Alzheimer's Disease: Graph theoretical analysis of cerebellar
network features based on 18F-AV45 PET.
PLoS One. 2026;21:e0342738.
PubMed
Abstract available
Clinical implementation of RECIP 1.0.
Semin Nucl Med. 2026;56:5-8.
PubMed
Abstract available
Artificial intelligence in nuclear cardiology: Technical perspectives, strategic
directions, and recommendations from an IAEA expert working group.
Semin Nucl Med. 2026;56:119-131.
PubMed
Abstract available
Response Evaluation Criteria in Grade 1/2 Neuroendocrine Tumors (RECIN).
Semin Nucl Med. 2026;56:22-30.
PubMed
Abstract available
Thank you for your interest in scientific medicine.